Change

Consolidated statement
of changes in equity


 

Attributable to shareholders of the company

 

 

 

 

 

 

 

 

 

 

 

 

In € millions

Sub-
scribed share capital

Additional paid-in capital

Cash flow hedge reserve

Reval-
uation reserve

Cumulative translation reserves

Other (statutory) reserves and undistributed profit

Share-
holders’ equity

Non-con-
trolling interests

Total equity

 

 

 

 

 

 

 

 

 

 

Balance at January 1, 2009

463

(49)

(1,130)

8,179

7,463

450

7,913

Profit for the period

285

285

77

362

Other comprehensive income

8

7

388

403

(3)

400

Reclassification into the statement of income

40

(2)

38

38

Tax on other comprehensive income

(5)

(33)

(38)

(38)

Comprehensive income

43

7

353

285

688

74

762

Dividend paid

(395)

(395)

(59)

(454)

Equity-settled transactions

15

15

15

Issue of common shares

2

2

4

4

Acquisitions and divestments

5

5

Balance at December 31, 2009

465

2

(6)

7

(777)

8,084

7,775

470

8,245

 

 

 

 

 

 

 

 

 

 

Profit for the period

754

754

83

837

Other comprehensive income

47

774

821

73

894

Reclassification into the statement of income

3

(20)

(17)

(17)

Tax on other comprehensive income

(15)

(20)

(35)

(35)

Comprehensive income

35

734

754

1,523

156

1,679

Dividend paid

(320)

(320)

(83)

(403)

Equity-settled transactions

27

27

27

Issue of common shares

2

7

9

9

Acquisitions and divestments

(30)

(30)

(18)

(48)

Balance at December 31, 2010

467

9

29

7

(43)

8,515

8,984

525

9,509

Keyword Search
Copyright © 2011 Akzo Nobel N.V.